Multiple Assemblies exist for SMTL entry 8rj7
The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing nanobody 1.29; X-RAY DIFFRACTION 2.10 Å

	SMTL ID 8rj7.1 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION Polypeptides Spike protein S1; Camel-derived nanobody 1.29 Oligo-state hetero-1-1-mer
	SMTL ID 8rj7.2 Ligands LYSINE; 2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION Polypeptides Spike protein S1; Camel-derived nanobody 1.29 Oligo-state hetero-1-1-mer
	SMTL ID 8rj7.3 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION Polypeptides Spike protein S1; Camel-derived nanobody 1.29 Oligo-state hetero-1-1-mer
	SMTL ID 8rj7.4 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION Polypeptides Spike protein S1; Camel-derived nanobody 1.29 Oligo-state hetero-1-1-mer
	SMTL ID 8rj7.5 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Spike protein S1; Camel-derived nanobody 1.29 Oligo-state hetero-1-1-mer